Oct 24, 2024 DLA Piper Genomics Series: Navigating Regulatory Challenges in the Era of Cell and Gene Therapies By Marion Abecassis Lyndsey Hudson Nicola Landolfi Ranulf Barman Marion de Galembert +2 more... Show less As healthcare moves towards personalised and precision medicine,[2] cell and gene therapies (CGTs) have emerged as cutting-edge and...
Oct 19, 2022 EU Pharma & Medical Device Regulation 2023 By Marco de Morpurgo Nicola Landolfi Our EU Life Sciences Regulatory team led by Marco de Morpurgo and Nicola Landolfi have produced a guide on EU Pharma & Medical Device...
Mar 12, 2024 Life Sciences Regulation in the EU: Overview By Marco de Morpurgo Nicola Landolfi Nadia Feola Heidi Waem +1 more... Show less DLA Piper's Life Sciences Regulatory team, led by Marco de Morpurgo, recently produced a Q&A guide to life sciences regulation in the EU...
May 17, 2021 Interactions with healthcare professionals – launch of the new DLA Piper interactive compliance site for pharmaceutical companies By Marco de Morpurgo Andrzej Balicki, Ph.D. Ethical relations with healthcare professionals are of vital importance for pharmaceutical companies. Cooperation with them results in a...
Jun 05, 2023 2023 Global M&A Intelligence Report – Life Sciences Supplement By Victoria Rhodes Robert Newman The DLA Piper Life Sciences sector team is delighted to announce the launch of our new 2023 Global M&A Intelligence Report – Life...
Apr 23, 2020 Clinical trials during the COVID-19 pandemic: A global guide By Dr Kokularajah Paheenthararajah After weeks of intensive collaboration and inspiring contributions from more than 100 Life Sciences enthusiasts across five continents,...
Jul 26, 2023 European Medicines Agency opens dialogue on use of AI in pharmaceutical life cycle By Danny Tobey Keo Shaw Marco de Morpurgo To open a dialogue with developers, academics, and regulators, the European Medicines Agency (EMA) recently published a draft Reflection...
Nov 23, 2020 Telehealth around the world: A global guide By Greg Bodulovic Marco de Morpurgo The COVID-19 pandemic has caused healthcare systems around the globe to rapidly, and in some cases, radically rethink the delivery of...
Jan 25, 2022 Update: DLA Piper Global COVID-19 Vaccine Guide for Employers By Marco de Morpurgo DLA Piper’s Life Sciences team has updated our recent vaccine guide for employers. The changes include significant updates to several...
Oct 05, 2021 Update: DLA Piper Global COVID-19 Vaccine Guide for Employers By Marco de Morpurgo DLA Piper’s Life Sciences team has updated our recent vaccine guide for employers. The changes include the additions of Sweden and...
May 25, 2021 Launch of DLA Piper Global COVID-19 Vaccine Guide for Employers By Pilar Menor Marco de Morpurgo As the scientific response to the COVID-19 pandemic develops, many employers are considering what their approach should be to the issues...
Mar 16, 2021 Wearable technologies: legal lifecycle of taking a new product to market By Marco de Morpurgo Wearable devices is a term used for electronic devices that can be worn on the body, either as an accessory like a watch or a pair of...
Jun 07, 2024 DLA Piper Life Sciences Index 2024 By Lyndsey Hudson Marco de Morpurgo Welcome to the first edition of the Life Sciences Index, a study about perceptions of innovation and growth in the life sciences...
Apr 03, 2020 European Commission proposes one-year postponement of MDR application date By Mark Franklin Marco de Morpurgo Paula Gonzalez de Castejón Llano-Ponte Nicola Landolfi +1 more... Show less Following an informal heads-up on 25 March 2020, today the European Commission adopted a proposed regulation to postpone by one year the...
May 15, 2024 New Belgian tax to combat medicine shortages costs By Jean-Christophe Top Marco de Morpurgo Nicolas Engelmann On Wednesday May 8th 2024, the Belgian Parliament adopted a new law to combat the costs arising from the unavailability of medicinal...
Apr 18, 2024 Managed Entry Agreements (MEAs) under scrutiny once more in Belgium By Jean-Christophe Top Joost Haans Marco de Morpurgo Lyndsey Hudson +1 more... Show less Impressive advancements in the pharma industry provide hope to patients affected by debilitating and life-threatening diseases and a...